New Product development

Presented By-RABIA BIBI 11777

SUNDUS MUKHTAR 11800

Definition

New product development (NPD) is the complete process of bringing a new product to the market till its consumption & feedback from the end user of the business chain through the systematic procedure & parameter.

It may be a Consumable product, service or idea.

Definition New product development (NPD) is the

complete process of bringing a new product or service to market.

New product development may be done to develop an item to compete with a particular product or may be done to improve an already established product.

Examples

This type of development is considered the preliminary step in product or service development and involves a number of steps that must be completed before the product can be introduced to the market.

New medicine New model of auto mobile New cellular phone

Agenda

Market Research/Opportunity Scan Concept Testing Prototype Development Market Testing Product Launch

Why New Products?

New product development is essential to any business that must keep up with market trends and changes.

Approximately one-third of the revenue a business generates is coming from products they did not sell five years ago

Changing environment creates new demands and needs

Product Development

Must be alert to quickly develop opportunities Focus on markets or product categories

consistent with organization’s objectives, resources, capabilities and strengths

Securing a competitive advantage

Industrial New Product Ideas

Company sources other than R&D 36.2% Analysis of the competition 27.0% Research & Development 24.3% Product users 15.8% Supplier suggestions 12.5% Product user research 10.5% Published information 7.9%

New Products necessity

A way of getting new and keeping old customers

Effective way of obtaining a competitive advantage

Source of growth and excitement

New Product Categories

New to the world products New product lines Product line extensions Improvements and revisions to existing

products Repositionings Cost reductions

Product Development Process

Market researchand

Opportunity scan

ConceptTesting

PrototypeDevelopment

TestMarketing

Product Launch

Marketing

Very important to product development success Key to successful marketing is imaginative,

effective, creative communication Find a need and fill it. Mutually beneficial exchange relationships

Market Opportunity and Threats

Economic Realities• GNP• Disposable Income• Discretionary Income

Legal & Regulatory Condition• Laws• Regulations

Societal Focus• Population Shifts• Values• Attitudes• Competition• Trends

Technological Development• Advance in

technology• Market receptiveness

to technology

Reasons For New Product Failures

Poor marketing research Technical problems Insufficient marketing effort Bad timing The wrong group was targeted. Unrealistic forecast. Insufficient level of awareness.

Summary

New product development drives growth. Market research is critical to the success of a

new product launch. Market research is a continuous process as

customer needs, your business and the environment changes.

FUZZY FRONT END

Speakers: Noor-ul-Ainn (11773)

Ammara Farooqui (11734)

What is Fuzzy Front End?

Fuzzy Front end is defined asActivities that come before the “formal and well structured” New Product Development (NPD) Portion.It is also described in literature as "Front End of Innovation", "Phase 0", "Stage 0" or "Pre-Project-Activities"

Activities are less structured and less predictable.

Structured with a formulized and précised set of activities and questions.

Why Focus FFE?Front End Innovation New Product Development

Nature of Work Experimental, often chaotic. “Eureka” moments. Can schedule work—but not invention.

Disciplined and goal-oriented with a project plan.

Commercialization Date

Unpredictable or uncertain. High degree of certainty.

Funding Variable—in the beginning phases many projects may be “bootlegged,” while others will need funding to proceed.

Budgeted.

Revenue Expectations Often uncertain, with a great deal of speculation.

Predictable, with increasing certainty, analysis, and documentation as the product release date gets closer.

Activity Individuals and team conducting research to minimize risk and optimize potential.

Multifunction product and/or process development team.

Measures of Progress Strengthened concepts. Milestone achievement.

New Concept Development Model (NCD)

Engine (Leadership, culture, and business strategy)The inner parts of the NCD are called elements, as opposed to processes. A process implies a structure that may not be applicable and could force the use of a set of poorly designed controls to manage FFE activities. In addition, the model has a circular shape, to suggest that ideas are expected to flow, circulate, and iterate between and among all the five elements. The flow may encompass the elements in any order or combination and may use one or more elements more than once.

Idea Identification:The essence of this element is the sources and methods used to identify opportunities to pursue. Opportunity identification in many cases precedes idea generation and enrichment. It also may enable linking unanticipated notions to business or marketplace needs that were not previously known. Opportunity identification may occur from a single person recognizing an unmet customer need or previously undetected problem.

Opportunity Analysis:Business capability and competency are assessed in this element, and sponsorship for further work will be determined. However, despite all of the effort, significant technology and market uncertainty will remain.In this element, an opportunity is assessed to confirm that it is worth pursuing. Additional information is needed for translating opportunity identification into specific business and technology opportunities. This involves making early and often uncertain technology and market assessments.

Idea Generation and EnrichmentThe element of idea generation and enrichment concerns the birth, development, and maturation of a concrete idea. Idea generation is evolutionary. Ideas are built up, torn down, combined, reshaped, modified, and upgraded. A new idea may also emerge outside the bounds of any formal process—such as an experiment that goes awry, a supplier offering a new material, or a user making an unusual request.

Idea SelectionThe problem for most businesses is in selecting which ideas to pursue in order to achieve the most business value. Formalized decision processes in the FFE are difficult due to the limited information and understanding that are available early in product development. Financial analyses and estimates of future income for ideas at this early stage are often wild guesses.

Concept DefinitionConcept definition is the final element of the new concept development model. This element provides the only exit to the NPD or technology stage gate (TSG). In order to pass through the gate, the innovator must make a compelling case for investment in the business or technology proposition. Some organizations refer to this as a “win statement.” Others call it a “gate document.” The investment case consists of both qualitative and quantitative information, which the gatekeepers use to make a determination.

Influencing factors (the environment)The FFE exists in an environment of influencing factors. The factors are the corporation’s organizational capabilities, customer and competitor influences, the outside world’s influences, and the depth and strength of enabling sciences and technology

NEW PRODUCT DEVELOPMENT EXECUTION

PRESENTED BY:

ANAM HASSAN HIRA ARSHAD

WHAT IS NEW PRODUCT DEVELOPMENT EXECUTION?

To create the next product in a company’s product line a design team goes through product development process steps. Starting with a product idea, the team moves through several stages to generate all the details and documents needed to get the product built. A NEW product development (NPD) process goes through the same steps, however as this product has not been developed by the team before, new risks and uncertainties are introduced and often additional information is documented and shared with manufacturing.

STEPS OF NPD EXECUTION

There are five basic steps in a new product development EXECUTION:

Concept Ideation Design Test and Release.

Concept :

The concept step sets basic direction and boundaries for the entire development process by clarifying the type of product, the problem the product solves and the financial and technical goals to be achieved by the product.

Ideation : During the ideation step the team brainstorms to discover some of the many ways a product can solve the problem and meet internal goals. Ideas are evaluated and the most promising are selected for further investigation.

Design :It’s in this step that the execution of the “best” way to create and construct the product happens. Engineering details are generated to flesh out the high level concepts from the ideation stage.

Test :

Testing verifies if the product meets the original goals or if additional refinement is needed.

Release:Once testing has confirmed that the product solves the problem and will meet the company goals; it is ready to start the new product introduction (NPI) process and get the product built!

CLINICAL TRIALS FOR PRODUCT DEVELOPEMENT

Speaker:MADIHA AHMED 11761BUSHRA KHAN 11742

CLINICAL TRIALS :

A research activity that involves administration of a test treatment to some experimental unit in order to evaluate the treatment.

Clinical Trials

Clinical Trials

• Clinical trials are conducted only

when,

-Satisfactory information has been gathered

on the quality of the nonclinical safety.

- Health authority/ethics

committee approval is granted in the

country where approval of the drug is

sought.

• Clinical Trial is the mainstay for

bringing out New Drugs to the

Market.

Drug Review Steps

Preclinical (animal) testing. An investigational new drug application (IND) : outlines what the sponsor of a new drug proposes for human testing in clinical

trials. Phase 1 studies Phase 2 studies Phase 3 studies

Submission of New Drug Application (NDA) is the formal step asking the FDA to

consider a drug for marketing approval.FDA reviewers will approve the

application or find it either "approvable" or "not approvable.“ Phase 4 studies

DRUG REVIEW STEPS : Preclinical Data

IND Filing

IND Approval

Phase I

Phase II

Phase III

NDA Filed

NDA Approval

Marketing Permission

Phase IV

DCGI

Mandatory Approval Points

Sponsor

Go/No Go

Decision

Points

CPD-Phases

CLINICAL PRODUCT DEVELOPMENT- PHASES:

Clinical Trials

Major areas are:• Pharmacodynamic studies in vivo in animals, In vitro preparation• Absorption, distribution , elimination studies (pharmacokinetics)• Acute ,sub acute, chronic toxicity studies (toxicity profile)• Therapeutic index (safety & efficacy evaluation)

PRECLINICAL TRIAL :

Phases Of Clinical Trials

Focused on tolerability and safety. 12-30 (150) healthy people (often males). Efficacy on biomarkers . Single and repeated doses. Increase dose levels. Interaction with other drugs. Pharmacokinetics. Explorative.

Phase I50-150people

Phase II100-200people

Phase III500-15000people

Phase IV studies continue

PHASE 1 TRIAL :

Phases Of Clinical Trials

Phase I50-150people

Phase II100-200people

Phase III500-15000people

Phase IV studies continue

PHASE 2 TRIAL :

50-1000 patients. Extensive monitoring. Safety and tolerability in patients. Often complicated design, explorative. Selection of optimal dose. Pharmacokinetics in patients. Effect in special populations. Explorative.

Phases Of Clinical Trials

Phase I50-150people

Phase II100-200people

Phase III500-15000people

Phase IV studies continue

PHASE 3 TRIAL :

500-15000 patients Effect is verified in the target population Forms the basis of the NDA, New Drug Application Interactions between drugs start to become measurable in the larger population Sub-groups start to be established Special features and problems show up Confirmative

Phases Of Clinical Trials

Phase I50-150people

Phase II100-200people

Phase III500-15000people

Phase IV studies continue

PHASE 4 TRIAL :

Often large 500-15000 patients Further investigation of efficacy and safety post approval Special populations New indications Marketing

Correlation